ArticleMolecular biology reports2025
Wip1 enhances genotoxic stress-induced autophagy via ULK1 dephosphorylation in Medulloblastoma cells.
Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundAutophagy is a conserved lysosomal degradation pathway crucial for cellular homeostasis and survival under stress, including genotoxic stress. WIP1 (PPM1D), a phosphatase that modulates the DNA damage response (DDR), is frequently overexpressed in medulloblastoma and may influence autophagy. This study aimed to investigate the role of WIP1 in genotoxic stress-induced autophagy in D283med medulloblastoma cells. METHODS AND
resultsD283med medulloblastoma cells were treated with etoposide (Eto) to induce genotoxic stress. Autophagy was assessed via LC3-II accumulation, p62 degradation, and LC3 puncta formation using Western blot and immunofluorescence. WIP1 activity was modulated using the selective inhibitor GSK2830371 (GSK). Etoposide increased WIP1 levels and promoted autophagy, which was further enhanced by co-treatment with chloroquine (CQ) or GSK. DDR activation was confirmed by phosphorylation of ATR, Chk1, and γH2AX. WIP1 inhibition elevated p-ULK1 (Ser638) levels, suggesting WIP1-dependent dephosphorylation of ULK1. Immunoprecipitation and confocal microscopy confirmed physical interaction between WIP1 and ULK1. Apoptosis was evaluated using Annexin V/7-AAD assay. Co-inhibition of autophagy and WIP1 enhanced etoposide-induced apoptosis, correlating with increased Bax, cleaved caspase-3, and p53 expression.
conclusionsWIP1 promotes autophagy under genotoxic stress via ULK1 dephosphorylation, contributing to tumor cell survival. Inhibition of WIP1 disrupts this protective mechanism and sensitizes cells to apoptosis. Targeting the WIP1-autophagy axis may enhance the efficacy of genotoxic chemotherapy in WIP1-overexpressing tumors.
Indexed as
Identifiers
40960576What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.